Clinical Trial Update: Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial is evaluating the safety of Enhertu (trastuzumab deruxtecan) in Indian patients with breast cancer, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: AstraZeneca | Conditions: BREAST CANCER | Phase 4 | Status: RECRUITING